Search Results

FILTER BY

1 - 12 of 123 matches

Sort by:
  • PresentationACC 2025

    Oral Semaglutide Reduces Cardiovascular Events in People with Type 2 Diabetes with Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary Results From the SOUL Randomized Trial

    Presenter:  

    Darren K. McGuire

    March 29, 2025

  • PresentationACC 2025

    STRIDE - Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes

    Presenter:  

    Marc P. Bonaca

    March 29, 2025

  • PresentationTHT 2025

    The Diabetes Paradox: Outcomes in Heart Failure Patients With Diabetes

    Presenter:  

    Navneet Sandhu

    February 12, 2025

  • PresentationTHT 2025

    Impact of Sitagliptin on Long-Term Outcomes in Heart Failure With Reduced Ejection Fraction in Type 2 Diabetes Patients: A Retrospective Cohort Study

    Presenter:  

    Thitiphan Srikulmontri

    February 12, 2025

  • PresentationTHT Abstracts 2025

    The Diabetes Paradox: Outcomes in Heart Failure Patients With Diabetes

    Presenter:  

    Navneet Sandhu

    February 11, 2025

  • PresentationTHT Abstracts 2025

    Impact of Sitagliptin on Long-Term Outcomes in Heart Failure With Reduced Ejection Fraction in Type 2 Diabetes Patients: A Retrospective Cohort Study

    Presenter:  

    Thitiphan Srikulmontri

    February 11, 2025

  • PresentationTCT 2024

    TCT 507: Evaluating Vascular Response to Biodegradable Polymer-Coated Sirolimus-Eluting Stents in Patients With Diabetes Mellitus Using Optical Coherence Tomography: The OCID Study

    Presenter:  

    Atul Abhyankar

    October 30, 2024

  • PresentationTCT 2024

    TCT 257: Impact of Diabetes on Coronary Artery Disease Patterns and PCI Outcomes

    Presenter:  

    Koshiro Sakai

    October 30, 2024

  • PresentationTCT 2024

    GLP1 Agonists, the Promise of SELECT and Implications for Diabetes Drugs in PCI Patients

    Presenter:  

    Donna Lin

    October 29, 2024

  • PresentationTCT 2024

    Diabetes and Obesity: Modulating Cardiometabolic Risks

    Presenter:  

    C. Michael Gibson

    October 28, 2024

  • PresentationTCT 2024

    TCT 483: One Year Follow-Up Effect of Renal Sympathetic Denervation After Percutaneous Coronary Intervention in Patients With Resistant Hypertension and Type 2 Diabetes Mellitus

    Presenter:  

    Daria Feshchenko

    October 28, 2024

  • PresentationTCT 2024

    TCT 446: Long-term Outcomes and Impact of Diabetes Mellitus in Patients Treated With Paclitaxel Coated Balloon for Drug-Eluted Stent Restenosis

    Presenter:  

    Gakuto Bando

    October 28, 2024